Clovis Oncology Valuation
| CLVSQDelisted Stock | 0.12 0.02 20.00% |
Clovis Oncology seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Clovis Oncology from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.46 %, return on asset of -0.3, and Operating Margin of (1.55) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Clovis Oncology's price fluctuation is very steady at this time. Calculation of the real value of Clovis Oncology is based on 3 months time horizon. Increasing Clovis Oncology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Clovis Oncology's intrinsic value may or may not be the same as its current market price of 0.12, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.12 | Real 0.0956 | Hype 0.12 |
The intrinsic value of Clovis Oncology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Clovis Oncology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Clovis Oncology helps investors to forecast how Clovis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clovis Oncology more accurately as focusing exclusively on Clovis Oncology's fundamentals will not take into account other important factors: Clovis Oncology Total Value Analysis
Clovis Oncology is currently projected to have takeover price of 0 with market capitalization of 17.39 M, debt of 606.73 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Clovis Oncology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 17.39 M | 606.73 M |
Clovis Oncology Investor Information
About 25.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Based on the key measurements obtained from Clovis Oncology's financial statements, Clovis Oncology is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Clovis Oncology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Clovis Oncology has an asset utilization ratio of 31.46 percent. This connotes that the Company is making USD0.31 for each dollar of assets. An increasing asset utilization means that Clovis Oncology is more efficient with each dollar of assets it utilizes for everyday operations.Clovis Oncology Ownership Allocation
Clovis Oncology holds a total of 144.96 Million outstanding shares. Almost 73.46 percent of Clovis Oncology outstanding shares are held by general public with 1.46 (percent) owned by insiders and only 25.08 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Clovis Oncology Profitability Analysis
The company reported the revenue of 148.76 M. Net Loss for the year was (264.52 M) with profit before overhead, payroll, taxes, and interest of 115.3 M.About Clovis Oncology Valuation
The pink sheet valuation mechanism determines Clovis Oncology's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Clovis Oncology based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Clovis Oncology. We calculate exposure to Clovis Oncology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Clovis Oncology's related companies.8 Steps to conduct Clovis Oncology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Clovis Oncology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Clovis Oncology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Clovis Oncology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Clovis Oncology's revenue streams: Identify Clovis Oncology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Clovis Oncology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Clovis Oncology's growth potential: Evaluate Clovis Oncology's management, business model, and growth potential.
- Determine Clovis Oncology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Clovis Oncology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Clovis Oncology Growth Indicators
Investing in growth stocks can be very risky. If the company such as Clovis Oncology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 129.1 M | |
| Retained Earnings | -2.9 B |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Clovis Pink Sheet
If you are still planning to invest in Clovis Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clovis Oncology's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |